SG11201705138QA - Aqueous ophthalmic solution - Google Patents

Aqueous ophthalmic solution

Info

Publication number
SG11201705138QA
SG11201705138QA SG11201705138QA SG11201705138QA SG11201705138QA SG 11201705138Q A SG11201705138Q A SG 11201705138QA SG 11201705138Q A SG11201705138Q A SG 11201705138QA SG 11201705138Q A SG11201705138Q A SG 11201705138QA SG 11201705138Q A SG11201705138Q A SG 11201705138QA
Authority
SG
Singapore
Prior art keywords
ophthalmic solution
aqueous ophthalmic
aqueous
solution
ophthalmic
Prior art date
Application number
SG11201705138QA
Other languages
English (en)
Inventor
Koji Inagaki
Naoki Matsumoto
Toshihiro Ogawa
Yukihisa Wakabayashi
Asuka Kamimura
Yoshihiro Oshita
Hitoshi Nakazawa
Isao Matsuoka
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56150716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201705138Q(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of SG11201705138QA publication Critical patent/SG11201705138QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C13/00—Assembling; Repairing; Cleaning

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
SG11201705138QA 2014-12-25 2015-12-25 Aqueous ophthalmic solution SG11201705138QA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014263003 2014-12-25
JP2015114595 2015-06-05
PCT/JP2015/086230 WO2016104704A1 (ja) 2014-12-25 2015-12-25 水性点眼液

Publications (1)

Publication Number Publication Date
SG11201705138QA true SG11201705138QA (en) 2017-07-28

Family

ID=56150716

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201705138QA SG11201705138QA (en) 2014-12-25 2015-12-25 Aqueous ophthalmic solution

Country Status (13)

Country Link
US (2) US10278985B2 (ja)
JP (3) JP6779614B2 (ja)
KR (3) KR101789019B1 (ja)
AR (1) AR105199A1 (ja)
BR (1) BR112017013841A2 (ja)
CA (1) CA2971689C (ja)
EA (1) EA034517B1 (ja)
MX (1) MX2017008277A (ja)
MY (1) MY182507A (ja)
PH (1) PH12017501096A1 (ja)
SG (1) SG11201705138QA (ja)
TW (1) TWI709405B (ja)
WO (1) WO2016104704A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017008277A (es) * 2014-12-25 2017-10-02 Santen Pharmaceutical Co Ltd Solucion oftalmica acuosa.
JP2017002035A (ja) * 2015-06-05 2017-01-05 参天製薬株式会社 ソフトコンタクトレンズが装用されたドライアイ患者の眼に点眼されるように用いられることを特徴とするドライアイ治療剤
TWI743858B (zh) * 2015-06-05 2021-10-21 日商參天製藥股份有限公司 使水性點眼液中之洛赫西定類安定化之方法
MX2020008925A (es) 2018-02-28 2020-10-01 Santen Pharmaceutical Co Ltd Composicion oftalmica que comprende dicuafosol y polimero cationico.
CN117771172A (zh) * 2019-08-27 2024-03-29 参天制药株式会社 含有地夸磷索或其盐、及聚乙烯吡咯烷酮的水性眼科用组合物
US11229549B2 (en) * 2019-09-18 2022-01-25 Vance M. Thompson Tear transplantation and multi-part contact lens with absorbent portion
CN115996705A (zh) * 2020-06-23 2023-04-21 株式会社泰俊制药 包含地夸磷索的眼用组合物
KR102365008B1 (ko) * 2020-06-23 2022-02-23 주식회사태준제약 디쿠아포솔을 포함하는 점안 조성물
KR102548710B1 (ko) 2020-12-24 2023-06-28 주식회사 종근당 디쿠아포솔 또는 이의 약제학적으로 허용가능한 염과 토코페롤을 함유하는 건성안 예방 또는 치료용 약제학적 조성물
JP7230169B2 (ja) * 2020-12-25 2023-02-28 参天製薬株式会社 ジクアホソルまたはその塩、銀塩およびイオン性等張化剤を含有する水性点眼液
WO2024010040A1 (ja) * 2022-07-06 2024-01-11 ロート製薬株式会社 眼科組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09301858A (ja) 1996-05-13 1997-11-25 Senju Pharmaceut Co Ltd グルコン酸クロルヘキシジン安定化水性薬剤
JPH10203960A (ja) * 1997-01-24 1998-08-04 Ofutekusu:Kk 点眼液組成物
JPH1160505A (ja) 1997-05-20 1999-03-02 Senju Pharmaceut Co Ltd 防腐組成物
JP2008222638A (ja) 2007-03-13 2008-09-25 Teika Seiyaku Kk 油成分含有眼用組成物
JP2009073788A (ja) 2007-09-21 2009-04-09 Teika Seiyaku Kk イソプロピルウノプロストン含有眼用組成物
JP5398452B2 (ja) * 2008-09-30 2014-01-29 大正製薬株式会社 点眼剤
CN102470115B (zh) * 2009-08-07 2014-04-30 日本乐敦制药株式会社 硅酮水凝胶隐形眼镜用眼科组合物
JP6047272B2 (ja) 2010-09-15 2016-12-21 テイカ製薬株式会社 角膜上皮障害治療用点眼剤
EA027736B1 (ru) * 2010-12-28 2017-08-31 Сантен Фармасьютикал Ко., Лтд. Глазной раствор, содержащий диквафозол, способ его получения и способ ингибирования образования нерастворимого осадка
TWI757799B (zh) * 2012-03-26 2022-03-11 日商參天製藥股份有限公司 水性點眼液之製造方法
MX2017008277A (es) * 2014-12-25 2017-10-02 Santen Pharmaceutical Co Ltd Solucion oftalmica acuosa.

Also Published As

Publication number Publication date
WO2016104704A1 (ja) 2016-06-30
US20190209599A1 (en) 2019-07-11
CA2971689A1 (en) 2016-06-30
KR101789019B1 (ko) 2017-10-20
MY182507A (en) 2021-01-25
TWI709405B (zh) 2020-11-11
CA2971689C (en) 2020-11-03
KR102330736B1 (ko) 2021-11-23
KR20180063381A (ko) 2018-06-11
JP6779614B2 (ja) 2020-11-04
EA201791467A1 (ru) 2017-11-30
JP2021008513A (ja) 2021-01-28
JP2022166223A (ja) 2022-11-01
KR101867791B1 (ko) 2018-06-15
BR112017013841A2 (ja) 2018-06-19
EA034517B1 (ru) 2020-02-17
TW201628626A (zh) 2016-08-16
US10278985B2 (en) 2019-05-07
PH12017501096A1 (en) 2017-11-27
US20170348344A1 (en) 2017-12-07
JP7128243B2 (ja) 2022-08-30
US10786526B2 (en) 2020-09-29
JP2016210759A (ja) 2016-12-15
AR105199A1 (es) 2017-09-13
KR20170067900A (ko) 2017-06-16
KR20170118255A (ko) 2017-10-24
MX2017008277A (es) 2017-10-02

Similar Documents

Publication Publication Date Title
IL249643A0 (en) Eye preparation
GB201419865D0 (en) Solution
HK1244689A1 (zh) 水性眼科組合物
SG11201506309SA (en) Eye massager
PT3206678T (pt) Escultura corporal
SG11201705138QA (en) Aqueous ophthalmic solution
EP3209331C0 (en) EYE SOLUTION
EP3110903A4 (en) Aqueous solution and methods for manufacture and use
HK1205924A1 (en) Eye massager
SG11201704737SA (en) Novel aqueous composition
IL250017A0 (en) Eye examination devices
ZA201605363B (en) Goggles
SG11201704740WA (en) Aqueous composition
HUE059052T2 (hu) Vizes szemészeti készítmény
AP2016009545A0 (en) Naphthyridinedione derivatives
AP2016009530A0 (en) Cycloalkyl-linked diheterocycle derivatives
SG11201702202UA (en) Aqueous composition
PT3193833T (pt) Solução de diálise
GB201401190D0 (en) Spectacles
ZA201703701B (en) Ophthalmic composition
IL251096A0 (en) Removal of bromide from aqueous solutions
EP3231427A4 (en) Aqueous liquid agent
GB201410046D0 (en) Balayan sunglasses
GB201420400D0 (en) Janus eye
TWM490587U (en) Eyeglasses